Ohad Karnieli | Chief Executive Officer and Co Founder
Atvio Biotechnology

Ohad Karnieli, Chief Executive Officer and Co Founder, Atvio Biotechnology

Dr Karnieli is the founder and CEO of ATvio Biotech, a lead cell & gene therapy CDMO located in Israel focuses on process development and virus manufacturing. Dr Karnieli earned his PhD from the Tel Aviv university and his MBA from the Haifa university. Dr Karnieli serves as the chair of the process and product development committee of the International Society for Cellular Therapies (ISCT). Additionally, Dr Karnieli runs his own consultancy services (Karnieli Ltd) for cell therapy process development, automation and cGMP manufacturing with innovative and proprietary cell therapy technologies.  Prior to founding Atvio, Dr Karnieli was the vice president of Technology and Manufacturing at Pluristem Therapeutics

Appearances:



Advanced Therapies and Regenerative Medicine Day 1 - Wednesday 16th May 2018 @ 17:05

Panel: A new landscape for investment and innovation in the UK

  • How do Innovate UK and its family of networks and innovation centres support innovative advanced therapy businesses?
  • How does government investment support the development of new partnerships and supply chains?
  • How will the UK’s Industrial Strategy drive growth in the sector?

 

back to speakers

World Advanced Therapies & Regenerative Medicine Congress

TO SPONSOR / EXHIBIT

Erica Baeta
+44 (0)207 092 1152
erica.baeta@terrapinn.com

TO SPEAK

Jessica Robinson
t/ +44 (0)207 092 1150
jessica.robinson@terrapinn.com

TO REGISTER

Issa Mauthoor
+44 (0)207 092 1257
issa.mauthoor@terrapinn.com